Open AccessSwitching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study
Author(s) -
Anne Mills,
José Ramón Arribas,
Jaime Andrade-Villanueva,
Giovanni DiPerri,
Jan van Lunzen,
Ellen Koenig,
Richard Elion,
Matthias Cavassini,
José Valdez Madruga,
Jason Brunetta,
David Shamblaw,
Edwin DeJesus,
Chloe Orkin,
David A. Wohl,
Indira Brar,
Jeffrey L. Stephens,
PierreMarie Girard,
Gregory Huhn,
Andrew Plummer,
Ya-Pei Liu,
Andrew Cheng,
Scott McCallister
Publication year - 2016
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/n9xj-ek27
Subject(s) - tenofovir alafenamide , tenofovir , human immunodeficiency virus (hiv) , medicine , antiretroviral drug , antiretroviral therapy , antiretroviral treatment , virology , open label , pharmacology , viral load , clinical trial